<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In an antithrombin-III (AT-III) deficient patient suffering from recurrent episodes of venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> requiring major surgery an attempt was made to institute antithrombotic protection by long-term stanozolol treatment supplemented during periods of thrombogenic exposure with subcutaneous <z:chebi fb="5" ids="28304">heparin</z:chebi> and, when needed, infusion of AT-III as plasma or concentrate </plain></SENT>
<SENT sid="1" pm="."><plain>Stanozolol raised the plasma levels of AT-III, demonstrating a sparing effect on the AT-III needed </plain></SENT>
<SENT sid="2" pm="."><plain>Despite the repeated exposures to major surgery, protection against <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> was complete, but the <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arterial disease</z:e> progressed and led to the demise of the patient </plain></SENT>
</text></document>